Eventide Asset Management, LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:00 pm Sale |
2022-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 0 0.000% |
-2,708,975 (Position Closed) |
Filing |
| 2022-02-14 12:00 pm Purchase |
2021-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 2,708,975 5.900% |
338,000 (+14.26%) |
Filing |
| 2021-02-12 4:10 pm Purchase |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 2,370,975 5.300% |
1,126,080 (+90.46%) |
Filing |